<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0169152</article-id>
<article-id pub-id-type="publisher-id">PONE-D-16-31414</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Head</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular system</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular system</subject><subj-group><subject>Eyes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular system</subject><subj-group><subject>Ocular anatomy</subject><subj-group><subject>Choroid</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Ocular system</subject><subj-group><subject>Ocular anatomy</subject><subj-group><subject>Choroid</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Ophthalmology</subject><subj-group><subject>Eye diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Confidence intervals</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiovascular medicine</subject><subj-group><subject>Cardiovascular imaging</subject><subj-group><subject>Angiography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Cardiovascular imaging</subject><subj-group><subject>Angiography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Imaging techniques</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Cardiovascular imaging</subject><subj-group><subject>Angiography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Radiology and imaging</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Cardiovascular imaging</subject><subj-group><subject>Angiography</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Imaging techniques</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Tomography</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Radiology and imaging</subject><subj-group><subject>Diagnostic radiology</subject><subj-group><subject>Tomography</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Choroidal Thickness in CSC: A Meta-Analysis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Guohai</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Tzekov</surname>
<given-names>Radouil</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Li</surname>
<given-names>Wensheng</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jiang</surname>
<given-names>Fangzheng</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mao</surname>
<given-names>Sihong</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tong</surname>
<given-names>Yuhua</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Ophthalmology, Quzhou People’s Hospital, Quzhou, Zhejiang, PR China</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Ophthalmology, University of South Florida, Tampa, Florida, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>The Roskamp Institute, Sarasota, Florida, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Xiamen Eye Center of Xiamen University, Xiamen, Fujian, PR China</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Cao</surname>
<given-names>Cong</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Suzhou University, CHINA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple"> <list-item><p><bold>Conceptualization:</bold> GC WL.</p></list-item> <list-item><p><bold>Data curation:</bold> GC SM FJ YT.</p></list-item> <list-item><p><bold>Formal analysis:</bold> GC SM.</p></list-item> <list-item><p><bold>Funding acquisition:</bold> WL.</p></list-item> <list-item><p><bold>Investigation:</bold> FJ YT.</p></list-item> <list-item><p><bold>Methodology:</bold> GC RT.</p></list-item> <list-item><p><bold>Project administration:</bold> WL.</p></list-item> <list-item><p><bold>Resources:</bold> GC SM FJ.</p></list-item> <list-item><p><bold>Software:</bold> GC SM.</p></list-item> <list-item><p><bold>Supervision:</bold> WL.</p></list-item> <list-item><p><bold>Validation:</bold> WL.</p></list-item> <list-item><p><bold>Visualization:</bold> FJ YT.</p></list-item> <list-item><p><bold>Writing – original draft:</bold> GC RT.</p></list-item> <list-item><p><bold>Writing – review &amp; editing:</bold> WL SM FJ YT.</p></list-item></list>
</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">drlws@qq.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>1</issue>
<elocation-id>e0169152</elocation-id>
<history>
<date date-type="received">
<day>5</day>
<month>8</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Chen et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0169152"/>
<abstract>
<sec id="sec001">
<title>Purpose</title>
<p>To evaluate the relationship between subfoveal choroidal thickness (SFCT) and eyes with central serous chorioretinopathy (CSC) versus fellow or control eyes.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>We performed a meta-analysis using databases including PubMed, Embase and ISI Web of Science to find relevant studies. Weighted mean difference (WMD) was calculated for the SFCT in CSC eyes, the unaffected fellow eyes and normal controls.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Twelve studies were selected for this meta-analysis, including 1108 eyes (397 CSC eyes, 228 unaffected fellow eyes and 483 eyes of normal controls). The meta-analysis clearly demonstrated that the subfoveal choiroid of eyes with a clinical presentation of CSC was thickened compared to unaffected fellow eyes (WMD = 52.81, 95% confidence interval (CI), 39.13–66.49, P&lt;0.00001) and was thickened compared to control eyes (WMD = 145.03, 95%CI, 121.33–168.73, P&lt;0.00001). The mean SFCT measurement of the unaffected fellow eyes showed also significantly increased choroidal thickness compared to that of normal control eyes (WMD = 77.20, 95% CI, 44.98–109.42, P&lt;0.00001). Similar results were obtained in a sub-analysis based on the same instrument.</p>
</sec>
<sec id="sec004">
<title>Conclusion</title>
<p>It is demonstrated that SFCT is significantly increased in eyes with clinical manifestation of CSC, and in the clinically non-manifested fellow eyes. These results support the hypothesis that CSC is a bilateral disorder with an initial unilateral clinical presentation.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>The study design, data collection and analysis, decision to publish, and preparation of the manuscript were supported by grants from the National Natural Science Foundation of China (No. 81570875 to WL [<ext-link ext-link-type="uri" xlink:href="http://www.nsfc.gov.cn" xlink:type="simple">http://www.nsfc.gov.cn</ext-link>]); the Health Systems Young Personnel Training Projects Foundation in Fujian Province of China (No. 2013-ZQN-JC-37 to WL [<ext-link ext-link-type="uri" xlink:href="http://www.fjhfpc.gov.cn" xlink:type="simple">http://www.fjhfpc.gov.cn</ext-link>]) and Science and Technology Program Foundation of Xiamen City in China (No. 3502720144044 to WL [<ext-link ext-link-type="uri" xlink:href="http://www.xminfo.net.cn" xlink:type="simple">http://www.xminfo.net.cn</ext-link>]).</funding-statement>
</funding-group>
<counts>
<fig-count count="6"/>
<table-count count="2"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Central serous chorioretinopathy (CSC) is a retinal disorder characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, changes most often confined to the macula, and associated with leakage of fluid through the RPE into the subretinal space [<xref ref-type="bibr" rid="pone.0169152.ref001">1</xref>–<xref ref-type="bibr" rid="pone.0169152.ref002">2</xref>]. Although targeted epidemiological studies have not been conducted, it is believed that CSC is a relatively common non-surgical retinopathy and typically affects young to middle-aged adults [<xref ref-type="bibr" rid="pone.0169152.ref003">3</xref>]. The clinical manifestation is typically unilateral at first visit (~96%) [<xref ref-type="bibr" rid="pone.0169152.ref004">4</xref>], with bilateral involvement likely increasing to 20%-40% over time [<xref ref-type="bibr" rid="pone.0169152.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0169152.ref006">6</xref>]. Several studies indicated that men are much more affected than women, with male-to-female ratios reported of up to 8:1 [<xref ref-type="bibr" rid="pone.0169152.ref007">7</xref>].</p>
<p>Two major hypotheses of the pathogenesis of CSC have been proposed: the choroidal dysfunction and the RPE dysfunction [<xref ref-type="bibr" rid="pone.0169152.ref008">8</xref>]. Although CSC was initially thought to originate in the RPE and be caused mainly by its dysfunction, in 1967 Gass proposed that hyperpermeability of the choriocapillaris might be the main cause [<xref ref-type="bibr" rid="pone.0169152.ref009">9</xref>]. In support of this hypothesis, choroidal abnormalities, e.g. diffuse or multifocal choroidal vascular hyperpermeability, have been demonstrated in patients with CSC by indocyanine green angiography (ICGA) [<xref ref-type="bibr" rid="pone.0169152.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0169152.ref011">11</xref>]. This hyperpermeability of the choroidal vessels appears much larger in area compared to the active leaks attributed to the RPE seen in fluorescein angiography, indicating a more widespread choroidal vascular dysfunction. Some studies indicate that genetic background may predispose to CSC and that thick choroids could be one of its phenotypic indicators [<xref ref-type="bibr" rid="pone.0169152.ref002">2</xref>].</p>
<p>While ICGA and some other methods of visualizing the choroid like laser Doppler flowmetry or ultrasound are generally useful for evaluating the vascular anatomy and the functional status or any abnormalities of the choroidal blood vessels, it is difficult to apply a quantitative analysis to its results, something which would be very desirable for early diagnosis, follow-up of progression and estimates of therapeutic efficacy. From that point of view, optical coherence tomography (OCT), and especially its relatively recent modification–spectral-domain OCT (SD-OCT), may be much better suited for quantifying retinal and choroidal changes in CSC. Thus, in 2008 Spaide et al. described a method to obtain images of the choroid using conventional SD-OCT instruments and to evaluate choroidal thickness measurements, which they called “enhanced depth imaging” OCT technique (EDI-OCT). They demonstrated the capabilities of this to visualize the full choroidal depth and measure the choroid thickness in a 5 by 15-degree rectangle centered on the fovea [<xref ref-type="bibr" rid="pone.0169152.ref012">12</xref>]. Since then, using that method many studies reported that the choroid in the subfoveal region in patients with CSC was thicker compared to the subfoveal choroid in eyes of normal control subjects [<xref ref-type="bibr" rid="pone.0169152.ref013">13</xref>–<xref ref-type="bibr" rid="pone.0169152.ref015">15</xref>]. Despite the abundance of literature on this toipic, to the best of our knowledge no meta-analysis have been published focusing on the relationship between subfoveal choroidal thickness (SFCT) in affected eyes of patients with CSC versus SFCT in contralateral (typically unaffected) eyes or eyes of normal control subjects. As recent relevant data appears to be available, we decided to conduct an independent assessment of the literature and to undertake a meta-analysis in order to get a more complete and precise understanding about the status of SFCT in patients with CSC.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="sec007">
<title>Search Strategy</title>
<p>We conducted searches of PubMed, Embase and ISI Web of Science, using the terms <italic>“choroidal thickness”</italic> and <italic>“central serous chorioretinopathy”</italic>. A manual search was performed by checking the reference lists of original reports and review articles to identify studies not yet included in the computerized databases. The final search was carried out on April 15, 2016. The language was restricted to English.</p>
</sec>
<sec id="sec008">
<title>Inclusion and Exclusion Criteria</title>
<p>Articles were considered eligible for inclusion in the meta-analysis if the studies met the following inclusion criteria: (1) evaluating the SFCT in patients with CSC, (2) Independent retrospective or prospective association study, and (3) With sufficient available data to estimate WMD with 95% CI. Abstracts from conferences, full texts without raw data available for retrieval, duplicate publications, letters, and review articles were excluded.</p>
</sec>
<sec id="sec009">
<title>Data Extraction</title>
<p>The data were extracted independently by two reviewers (G.C. and W.L.). Disagreement was resolved by discussion. The information extracted from each study included the authors of each study, the year of reported, information on study design, location of the trial, instruments, number of subjects and SFCT.</p>
</sec>
<sec id="sec010">
<title>Qualitative Assessment</title>
<p>We assessed quality of included studies by a modified checklist based on the Newcastle-Ottawa Scale (NOS) [<xref ref-type="bibr" rid="pone.0169152.ref016">16</xref>], in which a study was judged on three categories: selection (four items, one star each), comparability (one item, up to two stars), and exposure/outcome (three items, one star each). A nine-point scale of the NOS (range, 0–9 points) has been developed for the evaluation. Studies were defined as high quality if they had more than seven points; as medium quality if they had between four and six points; and as poor quality if they had fewer than four points. Studies with NOS score above 4 points were included in the final analysis.</p>
</sec>
<sec id="sec011">
<title>Statistical Analysis</title>
<p>The quantitative data were entered into Cochrane Review Manager (RevMan, software version 5.1, Copenhagen, Denmark: The Nordic Cochrane Center, The Cochrane Collaboration, 2011). The WMD was determined for SFCT in the CSC eyes, the unaffected fellow eyes and the eyes of normal controls, outcome was reported with a 95% CI. P&lt;0.05 was considered statistically significant on the test for overall effect. The I<sup>2</sup> statistic was calculated to assess heterogeneity between studies (P&lt;0.05 was considered representative of significant statistical heterogeneity) [<xref ref-type="bibr" rid="pone.0169152.ref017">17</xref>]. If there was heterogeneity between studies, a random-effects model was applied to the data. Alternatively, a fixed-effects model was used for pooling the data. Begg’s rank correlation test and Egger’s linear regression test were employed to quantitatively assess publication bias (P&lt;0.05 was considered representative of significant statistical publication bias) [<xref ref-type="bibr" rid="pone.0169152.ref018">18</xref>,<xref ref-type="bibr" rid="pone.0169152.ref019">19</xref>].</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Overall Characteristics of Selected Studies and Quality Assessment</title>
<p>A total of 156 articles were initially identified. Of these, 143 were rejected according to the exclusion criteria and one without sufficient available data[<xref ref-type="bibr" rid="pone.0169152.ref013">13</xref>]. Hence, 12 studies were included in this meta-analysis [<xref ref-type="bibr" rid="pone.0169152.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0169152.ref015">15</xref>,<xref ref-type="bibr" rid="pone.0169152.ref020">20</xref>–<xref ref-type="bibr" rid="pone.0169152.ref029">29</xref>]. <xref ref-type="fig" rid="pone.0169152.g001">Fig 1</xref> provides a flow diagram of the search procedure and results. In total, the results from SFCT measurements in 1108 eyes were analyzed, including measurements from 397 eyes with clinical manifestation of CSC, 228 unaffected fellow eyes and 483 eyes of normal control subjects. According to the NOS used for quality assessment, two studies had moderate quality scores of 6, while ten studies had high quality scores of 7 or 8. The average score of all studies included in the analysis was 6.92. Ten studies employed “standard penetration” SD-OCT instruments using the EDI technique to obtain choroidal thickness data. Six of the studies used the Spectralis SD-OCT (Heidelberg Engineering, Heidelberg, Germany) [<xref ref-type="bibr" rid="pone.0169152.ref014">14</xref>,<xref ref-type="bibr" rid="pone.0169152.ref020">20</xref>,<xref ref-type="bibr" rid="pone.0169152.ref022">22</xref>,<xref ref-type="bibr" rid="pone.0169152.ref023">23</xref>,<xref ref-type="bibr" rid="pone.0169152.ref026">26</xref>,<xref ref-type="bibr" rid="pone.0169152.ref028">28</xref>], three of the studies used the 3D OCT-1000 (Topcon Corporation, Tokyo, Japan) [<xref ref-type="bibr" rid="pone.0169152.ref024">24</xref>,<xref ref-type="bibr" rid="pone.0169152.ref027">27</xref>,<xref ref-type="bibr" rid="pone.0169152.ref029">29</xref>], and one study used the RS-3000 Advance system (NIDEK, Gamagori, Japan) [<xref ref-type="bibr" rid="pone.0169152.ref025">25</xref>]. In addition, two studies used “high-penetration” SD-OCT instruments, which use light sources with a center wavelength of approximately 1050 nm, allowing greater penetration through the RPE and better imaging of the deep choroid compared to the other “standard penetration” SD-OCT instruments mentioned above using light sources centered at the wavelength range of 850–880 nm. One of these two studies used Cirrus HD-OCT (Carl Zeiss Meditec, La Jolla, CA) [<xref ref-type="bibr" rid="pone.0169152.ref015">15</xref>], and the other study used swept-source OCT (Topcon, Inc., Tokyo, Japan) [<xref ref-type="bibr" rid="pone.0169152.ref021">21</xref>]. The characteristics of the studies included are summarized in <xref ref-type="table" rid="pone.0169152.t001">Table 1</xref>.</p>
<fig id="pone.0169152.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Flow diagram describing selection of studies about association between choroidal thickness and CSC status.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.g001" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0169152.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.t001</object-id>
<label>Table 1</label> <caption><title>Characteristics of the included studies and quality scores on the association between choroidal thickness and CSC status.</title></caption>
<alternatives>
<graphic id="pone.0169152.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Study group / year</th>
<th align="center">Design</th>
<th align="center">Location</th>
<th align="center">Instrument</th>
<th align="center">No. of eyes<xref ref-type="table-fn" rid="t001fn001">*</xref></th>
<th align="center">Mean age <xref ref-type="table-fn" rid="t001fn002"><sup>†</sup></xref> (years)</th>
<th align="center">Refractive errors<xref ref-type="table-fn" rid="t001fn001">*</xref></th>
<th align="center">Quality score</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Goktas 2014</td>
<td align="center">Prospective</td>
<td align="center">Turkey</td>
<td align="center">Heidelberg Spectralis</td>
<td align="center">20 / 20 / 20</td>
<td align="center">41.2 / 39.3</td>
<td align="center">NA / NA / NA</td>
<td align="center">6</td>
</tr>
<tr>
<td align="center">Jirarattanasopa 2012</td>
<td align="center">Prospective</td>
<td align="center">Japan</td>
<td align="center">Topcon SS-OCT</td>
<td align="center">44 / 19 / 17</td>
<td align="center">57.3 / 62.1</td>
<td align="center">-0.8 / NA / 0.1</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Kang 2013</td>
<td align="center">Retrospective</td>
<td align="center">Korea</td>
<td align="center">Heidelberg Spectralis</td>
<td align="center">16 /—/ 32</td>
<td align="center">48.2 / 45.0</td>
<td align="center">NA / -0.55 / -1.14</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Kim JH 2013</td>
<td align="center">Retrospective</td>
<td align="center">Korea</td>
<td align="center">Heidelberg Spectralis</td>
<td align="center">40/—/40</td>
<td align="center">46.1 / 65.5</td>
<td align="center">0.13 /—/ NA</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Kim SW 2011</td>
<td align="center">Retrospective</td>
<td align="center">Korea</td>
<td align="center">Topcon 3D-1000</td>
<td align="center">31 /—/ 29</td>
<td align="center">47.4 / 59.8</td>
<td align="center">-0.6 /—/ 0.18</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Kim YT 2011</td>
<td align="center">Prospective</td>
<td align="center">Korea</td>
<td align="center">Heidelberg Spectralis</td>
<td align="center">30 / 30 / 30</td>
<td align="center">48.2 / 48.2</td>
<td align="center">-0.5 /—/ -1.3</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Kuroda 2013</td>
<td align="center">Retrospective</td>
<td align="center">Japan</td>
<td align="center">Zeiss Cirrus HD-OCT</td>
<td align="center">35 /—/ 35</td>
<td align="center">54.4 / 53.9</td>
<td align="center">-0.51 /—/ -0.72</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Manabe 2015</td>
<td align="center">Prospective</td>
<td align="center">Japan</td>
<td align="center">Nidek RS-3000</td>
<td align="center">22 /—/ 54</td>
<td align="center">55.0 / 54.1</td>
<td align="center">NA /—/ NA</td>
<td align="center">6</td>
</tr>
<tr>
<td align="center">Maruko 2011</td>
<td align="center">Retrospective</td>
<td align="center">Japan</td>
<td align="center">Heidelberg Spectralis</td>
<td align="center">66 / 66 / 177</td>
<td align="center">52.8 / 55.6</td>
<td align="center">-1.6 / -1.4 / -1.4</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Oh 2014</td>
<td align="center">Retrospective</td>
<td align="center">Korea</td>
<td align="center">Topcon 3D-1000</td>
<td align="center">44 / 44 / -</td>
<td align="center">46.5 / NA</td>
<td align="center">-1.4 / -1.3 / -</td>
<td align="center">8</td>
</tr>
<tr>
<td align="center">Yang 2013</td>
<td align="center">Prospective</td>
<td align="center">China</td>
<td align="center">Heidelberg Spectralis</td>
<td align="center">15 / 15 / 15</td>
<td align="center">46.0 / 46.5</td>
<td align="center">-0.27 / NA / -0.51</td>
<td align="center">7</td>
</tr>
<tr>
<td align="center">Yun 2015</td>
<td align="center">Retrospective</td>
<td align="center">Korea</td>
<td align="center">Topcon 3D-1000</td>
<td align="center">34 / 34 / 34</td>
<td align="center">47.8 / 47.8</td>
<td align="center">-0.79 / -0.81 /-0.49</td>
<td align="center">7</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>* Central serous chorioretinopathy eyes/unaffected fellow eyes /normal controls</p></fn>
<fn id="t001fn002"><p>† Central serous chorioretinopathy patients/normal controls;—without unaffected fellow eyes or normal controls</p></fn>
<fn id="t001fn003"><p>NA, not available.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec014">
<title>Subfoveal Choroidal Thickness</title>
<p>When the data from all studies were combined, the mean SFCTs of the affected eyes, unaffected fellow eyes, and normal control eyes were 413.1 ± 93.0 μm, 337.9 ± 90.9 μm, 277.6 ± 73.4 μm, respectively. Adjusting the mean by obtaining a weighted average of SFCTs with weights based on the number of eyes involved in each study resulted in similar values (<xref ref-type="table" rid="pone.0169152.t002">Table 2</xref>). Overall, 11 studies involving 836 eyes compared choroidal thickness of CSC eyes to the thickness in eyes of normal control subjects, 6 studies involving 477 eyes compared choroidal thickness of unaffected fellow eyes of CSC patients to choroidal thickness in eyes of normal controls, and 7 studies involving 456 eyes compared thickness in CSC eyes to thickness in unaffected fellow eyes. As an initial task, we compared the SFCT of the eyes with clinical manifestation of CSC to SFCT of control eyes. This comparison clearly demonstrated that CSC-affected eyes had SFCT which was ~145 μm (34%) bigger compared to normal control’ eyes (weighted mean difference (WMD) = 145.03, 95% confidence interval (CI), 121.33–168.73) and that this difference was highly significant (P&lt;0.00001), with heterogeneity identified. Because of the presence of heterogeneity, a random-effects model was applied to the data (<xref ref-type="fig" rid="pone.0169152.g002">Fig 2</xref>). Similarly, the analysis demonstrated that the SFCT of the clinically unaffected fellow eyes was ~77 μm (~29%) bigger compared to the thickness in normal control eyes (WMD = 77.20, 95% CI, 44.98–109.42) and this difference was also highly significant (P&lt;0.00001). Heterogeneity was present in this comparison too, and thus, a random-effects model was applied to the data (<xref ref-type="fig" rid="pone.0169152.g003">Fig 3</xref>). Finally, when comparing the mean SFCT of the CSC-affected eyes to the choroidal thickness in unaffected fellow eyes, the analysis demonstrated a subfoveal choroid which was on average ~53 μm (~20%) thicker compared to unaffected fellow eyes (WMD = 52.81, 95% CI, 39.13–66.49) and this difference was also highly significant (P&lt;0.00001), with no heterogeneity identified (<xref ref-type="fig" rid="pone.0169152.g004">Fig 4</xref>).</p>
<fig id="pone.0169152.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Random-effects model evaluating the association between subfoveal choroidal thickness in CSC eyes and normal control eyes.</title>
<p>CSC, central serous chorioretinopathy; SD, standard deviation; IV, inverse variance; CI, confidence interval.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.g002" xlink:type="simple"/>
</fig>
<fig id="pone.0169152.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Random-effects model evaluating the association between subfoveal choroidal thickness in unaffected fellow eyes and normal control eyes.</title>
<p>SD, standard deviation; IV, inverse variance; CI, confidence interval.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.g003" xlink:type="simple"/>
</fig>
<fig id="pone.0169152.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Meta-analysis of the association between subfoveal choroidal thickness in CSC eyes and unaffected fellow eyes.</title>
<p>CSC, central serous chorioretinopathy; SD, standard deviation; IV, inverse variance; CI: confidence interval.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.g004" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0169152.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.t002</object-id>
<label>Table 2</label> <caption><title>Mean values and standard deviations of subfoveal choroidal thickness in all studies included in the current meta-analysis.</title></caption>
<alternatives>
<graphic id="pone.0169152.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Study</th>
<th align="center" colspan="3">CSC eyes</th>
<th align="center" colspan="3">Unaffected fellow eyes</th>
<th align="center" colspan="3">Control eyes</th>
</tr>
<tr>
<th align="center">Mean</th>
<th align="center">SD</th>
<th align="center">n</th>
<th align="center">Mean</th>
<th align="center">SD</th>
<th align="center">n</th>
<th align="center">Mean</th>
<th align="center">SD</th>
<th align="center">n</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Goktas 2011</td>
<td align="center">461.4</td>
<td align="center">101.4</td>
<td align="center">20</td>
<td align="center">375.3</td>
<td align="center">103.7</td>
<td align="center">20</td>
<td align="center">287.6</td>
<td align="center">62.5</td>
<td align="center">20</td>
</tr>
<tr>
<td align="center">Jirarattanasopa 2012</td>
<td align="center">374.3</td>
<td align="center">92.9</td>
<td align="center">44<xref ref-type="table-fn" rid="t002fn001"><sup>*</sup></xref></td>
<td align="center">287.6</td>
<td align="center">101.6</td>
<td align="center">19</td>
<td align="center">248.4</td>
<td align="center">77.4</td>
<td align="center">17</td>
</tr>
<tr>
<td align="center">Kang 2013</td>
<td align="center">459.2</td>
<td align="center">77.5</td>
<td align="center">16</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">295.2</td>
<td align="center">73.3</td>
<td align="center">32</td>
</tr>
<tr>
<td align="center">Kim JH 2013</td>
<td align="center">436.8</td>
<td align="center">92.8</td>
<td align="center">40</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">256.9</td>
<td align="center">68.1</td>
<td align="center">40</td>
</tr>
<tr>
<td align="center">Kim SW 2011</td>
<td align="center">367.8</td>
<td align="center">105.6</td>
<td align="center">31</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">242.0</td>
<td align="center">66.4</td>
<td align="center">29</td>
</tr>
<tr>
<td align="center">Kim YT 2011</td>
<td align="center">445.6</td>
<td align="center">100.3</td>
<td align="center">30</td>
<td align="center">378.4</td>
<td align="center">117.4</td>
<td align="center">30</td>
<td align="center">266.8</td>
<td align="center">55.5</td>
<td align="center">30</td>
</tr>
<tr>
<td align="center">Kuroda 2013</td>
<td align="center">475.0</td>
<td align="center">138.0</td>
<td align="center">35<xref ref-type="table-fn" rid="t002fn002"><sup>†</sup></xref></td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">372.0</td>
<td align="center">120.0</td>
<td align="center">35</td>
</tr>
<tr>
<td align="center">Manabe 2015</td>
<td align="center">390.3</td>
<td align="center">116.3</td>
<td align="center">22</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">263.6</td>
<td align="center">97.6</td>
<td align="center">54</td>
</tr>
<tr>
<td align="center">Maruko 2011</td>
<td align="center">414.0</td>
<td align="center">109.0</td>
<td align="center">66</td>
<td align="center">350.0</td>
<td align="center">116.0</td>
<td align="center">66</td>
<td align="center">250.0</td>
<td align="center">75.0</td>
<td align="center">177</td>
</tr>
<tr>
<td align="center">Oh 2014</td>
<td align="center">308.1</td>
<td align="center">55.4</td>
<td align="center">44</td>
<td align="center">271.1</td>
<td align="center">48.6</td>
<td align="center">44</td>
<td align="center">/</td>
<td align="center">/</td>
<td align="center">/</td>
</tr>
<tr>
<td align="center">Yang 2013</td>
<td align="center">455.0</td>
<td align="center">73.0</td>
<td align="center">15</td>
<td align="center">387.0</td>
<td align="center">94.0</td>
<td align="center">15</td>
<td align="center">289.0</td>
<td align="center">71.0</td>
<td align="center">15</td>
</tr>
<tr>
<td align="center">Yun 2015</td>
<td align="center">369.7</td>
<td align="center">54.2</td>
<td align="center">34</td>
<td align="center">316.2</td>
<td align="center">54.7</td>
<td align="center">34</td>
<td align="center">281.9</td>
<td align="center">41.0</td>
<td align="center">34</td>
</tr>
<tr>
<td align="center" style="border-top:thick">Average</td>
<td align="center" style="border-top:thick">413.1</td>
<td align="center" style="border-top:thick">93.0</td>
<td align="center" style="border-top:thick">/</td>
<td align="center" style="border-top:thick">337.9</td>
<td align="center" style="border-top:thick">90.9</td>
<td align="center" style="border-top:thick">/</td>
<td align="center" style="border-top:thick">277.6</td>
<td align="center" style="border-top:thick">73.4</td>
<td align="center" style="border-top:thick">/</td>
</tr>
<tr>
<td align="center">Weighted average<xref ref-type="table-fn" rid="t002fn003"><sup>‡</sup></xref></td>
<td align="center">405.0</td>
<td align="center">96.1</td>
<td align="center">397<xref ref-type="table-fn" rid="t002fn004"><sup>§</sup></xref></td>
<td align="center">332.9</td>
<td align="center">94.9</td>
<td align="center">228<xref ref-type="table-fn" rid="t002fn004"><sup>§</sup></xref></td>
<td align="center">269.4</td>
<td align="center">77.6</td>
<td align="center">483<xref ref-type="table-fn" rid="t002fn004"><sup>§</sup></xref></td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>* - 35% of the eye have bilateral involvement.</p></fn>
<fn id="t002fn002"><p>† - 29.6% of the eyes have bilateral involvement.</p></fn>
<fn id="t002fn003"><p>‡—Weighted average was calculated by using weights based on the number of eyes involved in each group.</p></fn>
<fn id="t002fn004"><p>§—Total number of eyes in that group.</p></fn>
<fn id="t002fn005"><p>SD, standard deviation; n, number of eyes involved in each group.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Sub-analysis: Studies Using the Same OCT Equipment</title>
<p>One limitation of the analysis when all studies are included is the heterogeneity introduced by the use of different OCT instruments, as shown in <xref ref-type="table" rid="pone.0169152.t001">Table 1</xref>. To overcome this problem, we decided to conduct a sub-analysis including only studies that used the same OCT equipment. As the most popular instrument was Spectralis (Heidelberg Engineering), only studies using this instrument were included in the sub-analysis. We hypothesized that restricting the analysis to studies using the same instrument would reduce or even completely eliminate the presence of significant heterogeneity (in the latter case eliminating the need for use of a random-effects model) and would also increase the WMD and reduce the range of the CI of the mean differences. The results of this sub-analysis were very similar to the results of the main analysis: a) the average thickness of subfoveal choroid of the CSC-affected eyes was ~171μm (38%) bigger compared to the thickness of subfoveal choroid in normal control eyes (WMD = 170.69, 95%CI, 154.54–186.84, P&lt;0.00001, <xref ref-type="fig" rid="pone.0169152.g005">Fig 5A</xref>); b) the choroid of the CSC-unaffected fellow eyes was ~101 μm (36%) thicker compared to the choroid in normal control eyes (WMD = 100.19, 95%CI, 78.89–121.49, P&lt;0.00001, <xref ref-type="fig" rid="pone.0169152.g005">Fig 5B</xref>); c) the choroid of CSC-affected eyes was ~ 69 μm (~16%) thicker compared to the one in unaffected fellow eyes (WMD = 68.99, 95% CI, 43.42–94.57, P&lt;0.00001, <xref ref-type="fig" rid="pone.0169152.g005">Fig 5C</xref>). The hypothesized effects of the sub-analysis were confirmed as no heterogeneity was identified in the first two comparisons, the WMD increased in all three comparisons and the CI range decreased in the first (CSC-affected vs. control eyes) and second (CSC-unaffected, fellow eyes vs. control eyes) comparisons. The CI range increased in the third comparison (CSC vs. fellow eyes) probably because of the weight given to one study (Oh et al. 2014) which had a much narrower CI compared to the rest of studies in the main analysis. In addition, Begg’s rank correlation test and Egger’s linear regression test indicated no publication bias for any of the parameters.</p>
<fig id="pone.0169152.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Sub-analysis based on measurement of subfoveal choroidal thickness using Spectralis SD-OCT.</title>
<p><bold>(A)</bold> CSC eyes vs. normal controls, <bold>(B)</bold> Unaffected fellow eyes vs. normal controls, and <bold>(C)</bold> CSC eyes vs. unaffected fellow eyes. CSC, central serous chorioretinopathy; SD, standard deviation; IV, inverse variance; CI, confidence interval.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.g005" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec016" sec-type="conclusions">
<title>Discussion</title>
<p>In this meta-analysis, we reviewed 12 relevant studies, including a total of 1108 eyes (397 eyes with CSC, 228 unaffected fellow eyes and 483 eyes of normal controls). The results from the group comparisons clearly demonstrated that the subfoveal choroid of the CSC-affected eyes and of the clinically-unaffected, contralateral eyes of the patient groups was thicker compared to the subfoveal choroid of normal control eyes. This was true for all studies included in the main analysis and in the sub-analysis and the difference was very highly significant (P &lt;&lt; 0.001).</p>
<p>Despite the considerable progress in increasing our capabilities to investigate retinal structure and function in health and disease especially over the last decade, the true pathophysiology of CSC is still not completely understood. The main location of dysfunction was previously thought to originate in the RPE because one or multiple leakages were seen on fluorescein angiography. However, Negi et al. reported that fluorescein diffused readily into blebs made over damaged RPE, but the subretinal fluid was resorbed more quickly than from blebs overlying normal RPE in rabbits [<xref ref-type="bibr" rid="pone.0169152.ref030">30</xref>]. This result questions whether CSC is caused simply by a passive "leak" from the choroid through the RPE barrier. Currently, the leading hypothesis regarding the pathobiological mechanism of CSC is postulated to be a hyperpermeability of the choroidal vessels and consequent increased choroidal hydrostatic pressure, which leads to accumulation of subretinal fluid [<xref ref-type="bibr" rid="pone.0169152.ref010">10</xref>,<xref ref-type="bibr" rid="pone.0169152.ref011">11</xref>].</p>
<p>Can increased permeability of choroidal blood vessels be associated with a thicker choroid? Iida et al. reported focal choroidal hyperpermeability in 96% of 105 eyes with CSC in Japanese patients in the late phase ICGA [<xref ref-type="bibr" rid="pone.0169152.ref031">31</xref>]. Hyperpermeable choroidal vasculature is thought to produce increased tissue hydrostatic pressure, resulting in pigment epithelial detachments with subsequent RPE defects, which in turn results in focal leakage into the subretinal space [<xref ref-type="bibr" rid="pone.0169152.ref032">32</xref>]. The hyperpermeability might cause choroidal thickening through accumulation of fluid, and the expansion of the choroidal vessels could play a partial role for the choroidal thickening. The current meta-analysis conclusively demonstrates that the subfoveal choroid in CSC eyes is thicker than the choroid in normal control eyes or in unaffected fellow eyes. Maruko et al. reported that although the choroid was thicker in the fellow eyes with choroidal vascular hyperpermeability on ICGA, the choroid was not thicker in the fellow eyes without hyperpermeability [<xref ref-type="bibr" rid="pone.0169152.ref026">26</xref>]. This result indicates a significant correlation between choroidal thickness and choroidal vascular hyperpermeability and may explain better previous findings by Spaide et al. describing choroidal vascular hyperpermeability in fellow eyes of CSC patients based on ICGA [<xref ref-type="bibr" rid="pone.0169152.ref003">3</xref>,<xref ref-type="bibr" rid="pone.0169152.ref033">33</xref>].</p>
<p>It remains unclear whether or not choroidal thickening on OCT may represent solely activity of CSC. One longitudinal follow-up of CSC eyes found that SFCT decreased ~9% after a spontaneous resolution in 16 eyes with spontaneously resolved CSC, but did not return to normal values [<xref ref-type="bibr" rid="pone.0169152.ref022">22</xref>]. Thus, there appears to be a threshold of choroidal thickness above which accumulation of subretinal fluid is much more likely to occur, leading to clinical symptoms of CSC (decreasing in visual acuity, blurring of central vision, double vison, etc.). If this is confirmed based on large, well-designed clinical trials, the assessment of choroidal thickness by SD-OCT may prove to be a useful clinical indictor for early detection, monitoring the progression of evaluating treatment efficacy in CSC. The current meta-analysis also convincingly demonstrated that SFCT was increased not only in CSC eyes, but also in unaffected fellow eyes, suggesting that CSC might be an essentially a bilateral disorder with (mostly) unilateral clinical presentation. The frequency of the bilaterality is reported at 20% to 40% in observational longitudinal studies [<xref ref-type="bibr" rid="pone.0169152.ref004">4</xref>–<xref ref-type="bibr" rid="pone.0169152.ref006">6</xref>]. Broad retinal functional disturbances as assessed by multifocal electroretinography or static perimetry of both eyes in patients with unilateral involvement of CSC also suggest a bilateral functional involvment [<xref ref-type="bibr" rid="pone.0169152.ref034">34</xref>–<xref ref-type="bibr" rid="pone.0169152.ref036">36</xref>]. As the frequency of bilateral cases was high in a long-term follow-up study, it is likely that some unilateral cases of CSC will become bilateral during follow-up. The fact that the mean SFCT in the current meta-analysis was on average ~29% (or ~16% in the sub-analysis) thicker in clinically unaffected fellow eyes compared to normal control eyes, but ~20% (or ~19% in the sub-analysis) thinner compared to CSC-affected eyes (<xref ref-type="table" rid="pone.0169152.t002">Table 2</xref>), supports the notion of a critical threshold in SFCT and a subclinical ‘latent’ phase in CSC in unaffected fellow eyes, that may precede a subsequent clinical manifestation of the disease in both eyes.</p>
<p>Furthermore, the differences in SFCT between the three groups established in the current work may have some clinical significance. It appears that, at least in predominantly East Asian populations, increased SFCT is a risk factor for development of CSC and, therefore, its measurement has the potential to be used as a screening tool. Recently, a threshold value of 395 μm was prosed as an upper limit of normal SFCT based on measurements in French families and literature [<xref ref-type="bibr" rid="pone.0169152.ref037">37</xref>]. The results from our analysis indicate that there is a considerable overlap in absolute values of SFCT between control eyes and eyes with a clinical presentation of CSC on one hand, and clinically-affected CSC eyes and fellow eyes, on the other hand. Because of this overlap, it would be important, especially in the context of a longitudinal follow-up, for the clinician to be aware of a level of SFCT at which the probability of a clinical manifestation of CSC would be considerably increased as it approaches levels characteristic of CSC-affected eyes. One way to define such “threshold of awareness” could be as a mid-point value between the average SFCT of control eyes + 1 SD and the average SFCT of clinically-affected CSC eyes– 1 SD. The least variable result for determining such a threshold could be obtained using the same method of measurement and the same instrument. For example, in our sub-analysis based on studies using only Spectralis SD-OCT, a “threshold of awareness” can be defined as ~347 μm, based on the aggregated results from the six studies selected for the sub-analysis and presented in <xref ref-type="fig" rid="pone.0169152.g005">Fig 5A</xref> (dotted line in <xref ref-type="fig" rid="pone.0169152.g006">Fig 6</xref>).</p>
<fig id="pone.0169152.g006" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0169152.g006</object-id>
<label>Fig 6</label>
<caption>
<title>Subfoveal choroidal thickness in control eyes and in eyes with a clinical presentation of CSC determined by using Spectralis SD-OCT.</title>
<p>Filled circles represent mean values of subfoveal choroidal thickness (SFCT) in eyes with clinical presentation of CSC, while filled squares represent mean valued of SFCT in control eyes. Error bars indicate standard deviations. Two enlarged symbols in the right end of the figure represent the average SFCT value for each group. The dotted line represents the mid point between the lower end of the standard deviation of CSC-affected eyes and the upper end of the standard deviation of the control eyes. CSC, central serous chorioretinopathy.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.g006" xlink:type="simple"/>
</fig>
<p>SFCT could also be considered as a biomarker in screening for corticosteroid sensitivity, as it has been shown that corticosteroid use can be a predisposing factor for CSC [<xref ref-type="bibr" rid="pone.0169152.ref002">2</xref>,<xref ref-type="bibr" rid="pone.0169152.ref004">4</xref>]. Finally, in several of the studies included in this work, this parameter was used as an indicator of treatment efficacy, and our data support a rational for doing that in addition to other treatment efficacy measures, like visual acuity, multifocal electroretinography, angiography leakage, etc.</p>
<p>This work may have some limitations. First, we cannot fully exclude publication bias. It is possible that some works, especially those published in languages other than English may have been missed. Second, a potential source of heterogeneity is the use of different instruments for choroidal thickness measurement, so the results should be interpreted with caution. However, the results from our sub-analysis based on studies using the same OCT equipment, with no heterogeneity identified, were similar to the results of the main analysis, thus arguing against a significant contribution of the type of instrument used to the differences observed between groups. Third, ethnic backgrounds were almost East-Asians. Although a recent study demonstrated that the difference in SFCT is not statistically significant between Asians, Africans and Caucasians after adjusting for age, refractive error and axial length [<xref ref-type="bibr" rid="pone.0169152.ref038">38</xref>], there has been some controversy regarding the prevalence of CSC in different ethnic groups, with some authors claiming that there is difference [<xref ref-type="bibr" rid="pone.0169152.ref039">39</xref>], while other authors disputing it [<xref ref-type="bibr" rid="pone.0169152.ref040">40</xref>]. Some studies also suggest that there are ethnic differences in the rates of bilateral and multifocal involvement and in severity [<xref ref-type="bibr" rid="pone.0169152.ref004">4</xref>]. Thus, future studies will need to expand to other backgrounds when data become available. Fourth, the mean age of the patients in this analysis was universally in the 40-50s, so our conclusions are valid only for this age group, although some studies have found that age does not have an effect on SFCT when the results are corrected for axial length [<xref ref-type="bibr" rid="pone.0169152.ref041">41</xref>]. Lastly, there are natural interocular variations of choroidal thickness [<xref ref-type="bibr" rid="pone.0169152.ref042">42</xref>], and other factors that can affect choroidal thickness, like smoking, axial length, central corneal thickness, and diastolic ocular perfusion pressure [<xref ref-type="bibr" rid="pone.0169152.ref041">41</xref>,<xref ref-type="bibr" rid="pone.0169152.ref043">43</xref>,<xref ref-type="bibr" rid="pone.0169152.ref044">44</xref>], most of which have not been accounted for in the studies included in the present analysis.</p>
<p>In conclusion, the present analysis firmly establishes an increased SFCT not only in clinically affected eyes with CSC, but also in clinically unaffected fellow eyes in East Asian patients. Despite some limitations, this result provides strong support to the hypothesis that CSC is an essentially a bilateral disorder with mostly unilateral clinical presentation.</p>
</sec>
<sec id="sec017">
<title>Supporting Information</title>
<supplementary-material id="pone.0169152.s001" mimetype="application/msword" position="float" xlink:href="info:doi/10.1371/journal.pone.0169152.s001" xlink:type="simple">
<label>S1 Checklist</label>
<caption>
<title>PRISMA Checklist.</title>
<p>(DOC)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="pone.0169152.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nicholson</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Noble</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Forooghian</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Meyerle</surname> <given-names>C</given-names></name>. <article-title>Central serous chorioretinopathy: update on pathophysiology and treatment</article-title>. <source>Surv Ophthalmol</source>. <year>2013</year>;<volume>58</volume>(<issue>2</issue>):<fpage>103</fpage>–<lpage>26</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.survophthal.2012.07.004" xlink:type="simple">10.1016/j.survophthal.2012.07.004</ext-link></comment> <object-id pub-id-type="pmid">23410821</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Daruich</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Matet</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Dirani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bousquet</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Farman</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis</article-title>. <source>Prog Retin Eye Res</source>. <year>2015</year>;<volume>48</volume>:<fpage>82</fpage>–<lpage>118</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.preteyeres.2015.05.003" xlink:type="simple">10.1016/j.preteyeres.2015.05.003</ext-link></comment> <object-id pub-id-type="pmid">26026923</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spaide</surname> <given-names>RF</given-names></name>, <name name-style="western"><surname>Campeas</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Haas</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yannuzzi</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Fisher</surname> <given-names>YL</given-names></name>, <name name-style="western"><surname>Guyer</surname> <given-names>DR</given-names></name>, <etal>et al</etal>. <article-title>Central serous chorioretinopathy in younger and older adults</article-title>. <source>Ophthalmology</source>. <year>1996</year>;<volume>103</volume>(<issue>12</issue>):<fpage>2070</fpage>–<lpage>80</lpage>. <object-id pub-id-type="pmid">9003341</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liew</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Quin</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Gillies</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Fraser-Bell</surname> <given-names>S</given-names></name>. <article-title>Central serous chorioretinopathy: a review of epidemiology and pathophysiology</article-title>. <source>Clin Experiment Ophthalmol</source>. <year>2013</year>;<volume>41</volume>(<issue>2</issue>):<fpage>201</fpage>–<lpage>14</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1442-9071.2012.02848.x" xlink:type="simple">10.1111/j.1442-9071.2012.02848.x</ext-link></comment> <object-id pub-id-type="pmid">22788735</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kitzmann</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Pulido</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Diehl</surname> <given-names>NN</given-names></name>, <name name-style="western"><surname>Hodge</surname> <given-names>DO</given-names></name>, <name name-style="western"><surname>Burke</surname> <given-names>JP</given-names></name>. <article-title>The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980–2002</article-title>. <source>Ophthalmology</source>. <year>2008</year>;<volume>115</volume>(<issue>1</issue>):<fpage>169</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2007.02.032" xlink:type="simple">10.1016/j.ophtha.2007.02.032</ext-link></comment> <object-id pub-id-type="pmid">18166410</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Castro-Correia</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Coutinho</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Rosas</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Maia</surname> <given-names>J</given-names></name>. <article-title>Long-term follow-up of central serous retinopathy in 150 patients</article-title>. <source>Doc Ophthalmol</source>. <year>1992</year>;<volume>81</volume>(<issue>4</issue>):<fpage>379</fpage>–<lpage>86</lpage>. <object-id pub-id-type="pmid">1486812</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liegl</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ulbig</surname> <given-names>MW</given-names></name>. <article-title>Central serous chorioretinopathy</article-title>. <source>Ophthalmologica</source>. <year>2014</year>;<volume>232</volume>(<issue>2</issue>):<fpage>65</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1159/000360014" xlink:type="simple">10.1159/000360014</ext-link></comment> <object-id pub-id-type="pmid">24776999</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gemenetzi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>De Salvo</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Lotery</surname> <given-names>AJ</given-names></name>. <article-title>Central serous chorioretinopathy: an update on pathogenesis and treatment</article-title>. <source>Eye (Lond)</source>. <year>2010</year>;<volume>24</volume>(<issue>12</issue>):<fpage>1743</fpage>–<lpage>56</lpage>.</mixed-citation></ref>
<ref id="pone.0169152.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gass</surname> <given-names>JD</given-names></name>. <article-title>Pathogenesis of disciform detachment of the neuroepithelium</article-title>. <source>Am J Ophthalmol</source>. <year>1967</year>;<volume>63</volume>(<issue>3</issue>):Suppl:<fpage>1</fpage>–<lpage>13</lpage>.</mixed-citation></ref>
<ref id="pone.0169152.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Piccolino</surname> <given-names>FC</given-names></name>, <name name-style="western"><surname>Borgia</surname> <given-names>L</given-names></name>. <article-title>Central serous chorioretinopathy and indocyanine green angiography</article-title>. <source>Retina</source>. <year>1994</year>;<volume>14</volume>(<issue>3</issue>):<fpage>231</fpage>–<lpage>42</lpage>. <object-id pub-id-type="pmid">7973118</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prünte</surname> <given-names>C</given-names></name>. <article-title>Indocyanine green angiographic findings in central serous chorioretinopathy</article-title>. <source>Int Ophthalmol</source>. <year>1995</year>;<volume>19</volume>(<issue>2</issue>):<fpage>77</fpage>–<lpage>82</lpage>. <object-id pub-id-type="pmid">8586500</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spaide</surname> <given-names>RF</given-names></name>, <name name-style="western"><surname>Koizumi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Pozzoni</surname> <given-names>MC</given-names></name>. <article-title>Enhanced depth imaging spectral-domain optical coherence tomography</article-title>. <source>Am J Ophthalmol</source>. <year>2008</year>;<volume>146</volume>(<issue>4</issue>):<fpage>496</fpage>–<lpage>500</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajo.2008.05.032" xlink:type="simple">10.1016/j.ajo.2008.05.032</ext-link></comment> <object-id pub-id-type="pmid">18639219</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Imamura</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Fujiwara</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Margolis</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Spaide</surname> <given-names>RF</given-names></name>. <article-title>Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy</article-title>. <source>Retina</source>. <year>2009</year>;<volume>29</volume>(<issue>10</issue>):<fpage>1469</fpage>–<lpage>73</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e3181be0a83" xlink:type="simple">10.1097/IAE.0b013e3181be0a83</ext-link></comment> <object-id pub-id-type="pmid">19898183</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>YT</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Bai</surname> <given-names>KH</given-names></name>. <article-title>Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy</article-title>. <source>Eye (Lond)</source>. <year>2011</year>;<volume>25</volume>(<issue>12</issue>):<fpage>1635</fpage>–<lpage>40</lpage>.</mixed-citation></ref>
<ref id="pone.0169152.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuroda</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ikuno</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yasuno</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Nakai</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Usui</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sawa</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Choroidal thickness in central serous chorioretinopathy</article-title>. <source>Retina</source>. <year>2013</year>;<volume>33</volume>(<issue>2</issue>):<fpage>302</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e318263d11f" xlink:type="simple">10.1097/IAE.0b013e318263d11f</ext-link></comment> <object-id pub-id-type="pmid">23064424</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stang</surname> <given-names>A</given-names></name>. <article-title>Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonran-domized studies in meta-analyses</article-title>. <source>Eur J Epidemiol</source>. <year>2010</year>;<volume>25</volume>(<issue>9</issue>):<fpage>603</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s10654-010-9491-z" xlink:type="simple">10.1007/s10654-010-9491-z</ext-link></comment> <object-id pub-id-type="pmid">20652370</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>DG</given-names></name>. <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source>. <year>2003</year>;<volume>327</volume>(<issue>7414</issue>):<fpage>557</fpage>–<lpage>60</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.327.7414.557" xlink:type="simple">10.1136/bmj.327.7414.557</ext-link></comment> <object-id pub-id-type="pmid">12958120</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname> <given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname> <given-names>M</given-names></name>. <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source>. <year>1994</year>;<volume>50</volume>(<issue>4</issue>):<fpage>1088</fpage>–<lpage>101</lpage>. <object-id pub-id-type="pmid">7786990</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Smith</surname> <given-names>GD</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname> <given-names>C</given-names></name>. <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source>. <year>1997</year>; <volume>315</volume>(<issue>7109</issue>):<fpage>629</fpage>–<lpage>34</lpage>. <object-id pub-id-type="pmid">9310563</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goktas</surname> <given-names>A</given-names></name>. <article-title>Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy</article-title>. <source>Eye (Lond)</source>. <year>2014</year>; <volume>28</volume>(<issue>12</issue>):<fpage>1431</fpage>–<lpage>6</lpage>.</mixed-citation></ref>
<ref id="pone.0169152.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jirarattanasopa</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Ooto</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tsujikawa</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Yamashiro</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Hangai</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hirata</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy</article-title>. <source>Ophthalmology</source>. <year>2012</year>;<volume>119</volume>(<issue>8</issue>)<fpage>1666</fpage>–<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2012.02.021" xlink:type="simple">10.1016/j.ophtha.2012.02.021</ext-link></comment> <object-id pub-id-type="pmid">22521082</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kang</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>YT</given-names></name>. <article-title>Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy</article-title>. <source>Eye (Lond)</source>. <year>2013</year>;<volume>27</volume>(<issue>3</issue>):<fpage>387</fpage>–<lpage>91</lpage>.</mixed-citation></ref>
<ref id="pone.0169152.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Kang</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SJ</given-names></name>. <article-title>Variability of subfoveal choroidal thickness measurements in patients with age-related macular degeneration and central serous chorioretinopathy</article-title>. <source>Eye (Lond)</source>. <year>2013</year>;<volume>27</volume>(<issue>7</issue>):<fpage>809</fpage>–<lpage>15</lpage>.</mixed-citation></ref>
<ref id="pone.0169152.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Kwon</surname> <given-names>SS</given-names></name>, <name name-style="western"><surname>Yoo</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Huh</surname> <given-names>K</given-names></name>. <article-title>Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretionopathy, and polypoidal choroidalvasculopathy</article-title>. <source>Retina</source>. <year>2011</year>;<volume>31</volume>(<issue>9</issue>):<fpage>1904</fpage>–<lpage>11</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e31821801c5" xlink:type="simple">10.1097/IAE.0b013e31821801c5</ext-link></comment> <object-id pub-id-type="pmid">21878855</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Manabe</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Shiragami</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hirooka</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Izumibata</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tsujikawa</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Shiraga</surname> <given-names>F</given-names></name>. <article-title>Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy</article-title>. <source>Am J Ophthalmol</source>. <year>2015</year>;<volume>159</volume>(<issue>4</issue>):<fpage>644</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajo.2015.01.006" xlink:type="simple">10.1016/j.ajo.2015.01.006</ext-link></comment> <object-id pub-id-type="pmid">25595669</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maruko</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Iida</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sugano</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Ojima</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sekiryu</surname> <given-names>T</given-names></name>. <article-title>Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy</article-title>. <source>Retina</source>. <year>2011</year>;<volume>31</volume>(<issue>8</issue>):<fpage>1603</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0b013e31820f4b39" xlink:type="simple">10.1097/IAE.0b013e31820f4b39</ext-link></comment> <object-id pub-id-type="pmid">21487334</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oh</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Togloom</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Huh</surname> <given-names>K</given-names></name>. <article-title>Biometric characteristics of eyes with central serous chorioretinopathy</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2014</year>;<volume>55</volume>(<issue>3</issue>),<fpage>1502</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1167/iovs.13-13183" xlink:type="simple">10.1167/iovs.13-13183</ext-link></comment> <object-id pub-id-type="pmid">24550360</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Jonas</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Wei</surname> <given-names>W</given-names></name>. <article-title>Choroidal vessel diameter in central serous chorioretinopathy</article-title>. <source>Acta Ophthalmol</source> <year>2013</year>;<volume>91</volume>(<issue>5</issue>):<fpage>e358</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/aos.12059" xlink:type="simple">10.1111/aos.12059</ext-link></comment> <object-id pub-id-type="pmid">23647989</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yun</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Oh</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Han</surname> <given-names>JY</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>SY</given-names></name>, <name name-style="western"><surname>Moon</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Huh</surname> <given-names>K</given-names></name>. <article-title>Peripapillary choroidal thickness in central serous chorioretinopathy: is choroid outside the macula also thick?</article-title> <source>Retina</source>. <year>2015</year>;<volume>35</volume>(<issue>9</issue>):<fpage>1860</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0000000000000539" xlink:type="simple">10.1097/IAE.0000000000000539</ext-link></comment> <object-id pub-id-type="pmid">25874368</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Negi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Marmor</surname> <given-names>MF</given-names></name>. <article-title>Experimental serous retinal detachment and focal pigment epithelial damage</article-title>. <source>Arch Ophthalmol</source> <year>1984</year>;<volume>102</volume>(<issue>3</issue>):<fpage>445</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">6703994</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iida</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Kishi</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hagimura</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Shimizu</surname> <given-names>K</given-names></name>. <article-title>Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy</article-title>. <source>Retina</source> <year>1999</year>;<volume>19</volume>,<fpage>508</fpage>–<lpage>512</lpage>. <object-id pub-id-type="pmid">10606450</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fujimoto</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Gomi</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Wakabayashi</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Sawa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tsujikawa</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Tano</surname> <given-names>Y</given-names></name>. <article-title>Morphologic changes in acute central serous chorioretinopathy evaluated by Fourier-domain optical coherence tomography</article-title>. <source>Ophthalmology</source>. <year>2008</year>;<volume>115</volume>(<issue>9</issue>):<fpage>1494</fpage>–<lpage>500</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2008.01.021" xlink:type="simple">10.1016/j.ophtha.2008.01.021</ext-link></comment> <object-id pub-id-type="pmid">18394706</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Spaide</surname> <given-names>RF</given-names></name>, <name name-style="western"><surname>Hall</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Haas</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Campeas</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Yannuzzi</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>Fisher</surname> <given-names>YL</given-names></name>, <etal>et al</etal>. <article-title>Indocyanine green videoangiography of older patients with central serous chorioretinopathy</article-title>. <source>Retina</source>. <year>1996</year>;<volume>16</volume>(<issue>3</issue>):<fpage>203</fpage>–<lpage>13</lpage>. <object-id pub-id-type="pmid">8789858</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marmor</surname> <given-names>MF</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>F</given-names></name>. <article-title>Central serous chorioretinopathy: bilateral multifocal electroretinographic abnormalities</article-title>. <source>Arch Ophthalmol</source>. <year>1999</year>;<volume>117</volume>(<issue>2</issue>):<fpage>184</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">10037562</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chappelow</surname> <given-names>AV</given-names></name>, <name name-style="western"><surname>Marmor</surname> <given-names>MF</given-names></name>. <article-title>Multifocal electroretinogram abnormalities persist following resolution of central serous chorioretinopathy</article-title>. <source>Arch Ophthalmol</source>. <year>2000</year>;<volume>118</volume>(<issue>9</issue>):<fpage>1211</fpage>–<lpage>5</lpage>. <object-id pub-id-type="pmid">10980766</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baran</surname> <given-names>NV</given-names></name>, <name name-style="western"><surname>Gürlü</surname> <given-names>VP</given-names></name>, <name name-style="western"><surname>Esgin</surname> <given-names>H</given-names></name>. <article-title>Long-term macular function in eyes with central serous chorioretinopathy</article-title>. <source>Clin Experiment Ophthalmol</source>. <year>2005</year>;<volume>33</volume>(<issue>4</issue>):<fpage>369</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1442-9071.2005.01027.x" xlink:type="simple">10.1111/j.1442-9071.2005.01027.x</ext-link></comment> <object-id pub-id-type="pmid">16033348</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lehmann</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bousquet</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Beydoun</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Behar-Cohen</surname> <given-names>F</given-names></name>. <article-title>PACHYCHOROID: an inherited condition?</article-title> <source>Retina</source>. <year>2015</year>;<volume>35</volume>(<issue>1</issue>):<fpage>10</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0000000000000287" xlink:type="simple">10.1097/IAE.0000000000000287</ext-link></comment> <object-id pub-id-type="pmid">25046398</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Karapetyan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ouyang</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Tang</surname> <given-names>LS</given-names></name>, <name name-style="western"><surname>Gemilyan</surname> <given-names>M</given-names></name>. <article-title>Choroidal thickness in relation to ethnicity measured using enhanced depth imaging optical coherence tomography</article-title>. <source>Retina</source>. <year>2016</year>;<volume>36</volume>(<issue>1</issue>):<fpage>82</fpage>–<lpage>90</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/IAE.0000000000000654" xlink:type="simple">10.1097/IAE.0000000000000654</ext-link></comment> <object-id pub-id-type="pmid">26098385</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yannuzzi</surname> <given-names>LA</given-names></name>. <article-title>Type A behavior and central serous chorioretinopathy</article-title>. <source>Trans Am Ophthalmol Soc</source>. <year>1986</year>;<volume>84</volume>:<fpage>799</fpage>–<lpage>845</lpage>. <object-id pub-id-type="pmid">3590481</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Desai</surname> <given-names>UR</given-names></name>, <name name-style="western"><surname>Alhalel</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Campen</surname> <given-names>TJ</given-names></name>, <name name-style="western"><surname>Schiffman</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Edwards</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Jacobsen</surname> <given-names>GR</given-names></name>. <article-title>Central serous chorioretinopathy in African Americans</article-title>. <source>J Natl Med Assoc</source>. <year>2003</year>;<volume>95</volume>(<issue>7</issue>),<fpage>553</fpage>–<lpage>9</lpage>. <object-id pub-id-type="pmid">12911253</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>XQ</given-names></name>, <name name-style="western"><surname>Larsen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Munch</surname> <given-names>IC</given-names></name>. <article-title>Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students</article-title>. <source>Invest Ophthalmol Vis Sci</source>. <year>2011</year>;<volume>52</volume>(<issue>11</issue>):<fpage>8438</fpage>–<lpage>41</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1167/iovs.11-8108" xlink:type="simple">10.1167/iovs.11-8108</ext-link></comment> <object-id pub-id-type="pmid">21917938</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kang</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Koh</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>SC</given-names></name>. <article-title>Discrepancy in subfoveal choroidal thickness in healthy adults with isometropia</article-title>. <source>Ophthalmology</source>. <year>2015</year>;<volume>122</volume>(<issue>11</issue>):<fpage>2363</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2015.05.015" xlink:type="simple">10.1016/j.ophtha.2015.05.015</ext-link></comment> <object-id pub-id-type="pmid">26077577</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sizmaz</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Küçükerdönmez</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pinarci</surname> <given-names>EY</given-names></name>, <name name-style="western"><surname>Karalezli</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Canan</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Yilmaz</surname> <given-names>G</given-names></name>. <article-title>The effect of smoking on choroidal thickness measured by optical coherence tomography</article-title>. <source>Br J Ophthalmol</source>. <year>2013</year>;<volume>97</volume>(<issue>5</issue>):<fpage>601</fpage>–<lpage>4</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bjophthalmol-2012-302393" xlink:type="simple">10.1136/bjophthalmol-2012-302393</ext-link></comment> <object-id pub-id-type="pmid">23418198</object-id></mixed-citation></ref>
<ref id="pone.0169152.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maul</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Chang</surname> <given-names>DS</given-names></name>, <name name-style="western"><surname>Boland</surname> <given-names>MV</given-names></name>, <name name-style="western"><surname>Ramulu</surname> <given-names>PY</given-names></name>, <name name-style="western"><surname>Jampel</surname> <given-names>HD</given-names></name>. <article-title>Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients</article-title>. <source>Ophthalmology</source>. <year>2011</year>;<volume>118</volume>(<issue>8</issue>):<fpage>1571</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ophtha.2011.01.016" xlink:type="simple">10.1016/j.ophtha.2011.01.016</ext-link></comment> <object-id pub-id-type="pmid">21492939</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>